The Effect of Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal on Allograft Vasculopathy in De-Novo Heart Transplant: Recipients: Results of the SCHEDULE Trial After 36 Months

被引：0
|
作者：
Arora, S. [1 ]
Solberg, O. [1 ]
Karason, K. [2 ]
Andersson, B. [2 ]
Gustafsson, F. [3 ]
Eiskjaer, H. [4 ]
Radegran, G. [5 ]
Gude, E. [1 ]
Ueland, T. [6 ]
Aukrust, P. [6 ]
Solbu, D. [7 ]
Dellgren, G. [2 ]
Andreassen, A. [1 ]
Gullestad, L. [1 ]
机构：
[1] Univ Oslo, Rikshosp, Oslo Univ Hosp, Cardiol, N-0027 Oslo, Norway
[2] Sahlgrens Univ Hosp, Cardiol, Gothenburg, Sweden
[3] Rigshosp, Cardiol, DK-2100 Copenhagen, Denmark
[4] Skejby Univ Hosp, Cardiol, Aarhus, Denmark
[5] Skane Univ Hosp, Cardiol, Lund, Sweden
[6] Univ Oslo, Rikshosp, Oslo Univ Hosp, Res Inst Internal Med, N-0027 Oslo, Norway
[7] Novartis Norge, Oslo, Norway
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2015年 / 34卷 / 04期
关键词：
D O I：
10.1016/j.healun.2015.01.225
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
212
引用
收藏
页码：S85 / S85
页数：1
相关论文
共 50 条
  • [1] The Effect of Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal on Allograft Vasculopathy in De-Novo Heart Transplant Recipients: Results of the Schedule Trial after 6 Years
    Arora, S.
    Karason, K.
    Gustafsson, F.
    Eiskjaer, H.
    Radegran, G.
    Aaberge, L.
    Gude, E.
    Solbu, D.
    Dellgren, G.
    Andreassen, A. K.
    Gullestad, L.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S36 - S36
  • [2] The Effect of Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal on Exercise Capacity in De-Novo Heart Transplant Recipients: Results of the SCHEDULE Trial After 36 Months
    Arora, S.
    Gude, E.
    Karason, K.
    Andersson, B.
    Bartfay, S.
    Solbu, D.
    Dellgren, G.
    Andreassen, A.
    Gullestad, L.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S299 - S299
  • [3] Everolimus initiation with early calcineurin inhibitor withdrawal reduced allograft vaculopathy in de-novo heart transplant recipients: results of the SCHEDULE trial
    Arora, S.
    Andersson, B.
    Gustafsson, F.
    Eiskjaer, H.
    Raadegran, G.
    Aaberge, L.
    Erikstad, I.
    Gude, E.
    Solbu, D.
    Gullestad, L.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 179 - 180
  • [4] Everolimus Initiation With Calcineurin Inhibitor Withdrawal Reduces Allograft Vasculopathy in De-Novo Heart Transplant Recipients
    Arora, S.
    Andersson, B.
    Gustafsson, E.
    Eiskjaer, H.
    Radegran, G.
    Aaberge, L.
    Erikstad, I.
    Gude, E.
    Ueland, T.
    Aukrust, P.
    Solbu, D.
    Dellgren, G.
    Andreassen, A.
    Gullestad, L.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S154 - S154
  • [5] The Effect of Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal on Allograft Vasculopathy Assessed by Virtual Histology: Results of the SCHEDULE Trial
    Arora, S.
    Solberg, O.
    Gustafsson, F.
    Karason, K.
    Eiskjaer, H.
    Botker, H. E.
    Radegran, G.
    Dellgren, G.
    Ioanes, D.
    Gude, E.
    Solbu, D.
    Andreassen, A. K.
    Gullestad, L.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S16 - S17
  • [6] Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Three-Year Results From the Randomized SCHEDULE Study
    Andreassen, A. K.
    Andersson, B.
    Gustafsson, F.
    Eiskjaer, H.
    Radegran, G.
    Gude, E.
    Jansson, K.
    Solbu, D.
    Karason, K.
    Arora, S.
    Dellgren, G.
    Gullestad, L.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (04) : 1238 - 1247
  • [7] Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant Recipients Three-Year Results of a Scandinavian Randomized Trial
    Arora, Satish
    Andreassen, Arne K.
    Karason, Kristjan
    Gustafsson, Finn
    Eiskjaer, Hans
    Botker, Hans Erik
    Radegran, Goran
    Gude, Einar
    Ioanes, Dan
    Solbu, Dag
    Dellgren, Goran
    Ueland, Thor
    Aukrust, Pal
    Gullestad, Lars
    [J]. CIRCULATION-HEART FAILURE, 2018, 11 (09) : e004050
  • [8] Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal in Heart Transplant Recipients: A Randomized Trial
    Andreassen, A. K.
    Andersson, B.
    Gustafsson, F.
    Eiskjaer, H.
    Rdegran, G.
    Gude, E.
    Jansson, K.
    Solbu, D.
    Sigurdardottir, V.
    Arora, S.
    Dellgren, G.
    Gullestad, L.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (08) : 1828 - 1838
  • [9] The Effect of Everolimus Initiation and Calcineurin Inhibitor Reduction on Allograft Vasculopathy in Maintenance Heart Transplant Recipients: Results of the NOCTET Trial After 5 Years
    Arora, S.
    Karason, K.
    Eisjaer, H.
    Botker, H.
    Gustafsson, F.
    Saunamaki, K.
    Radegran, G.
    Gude, E.
    Aaberge, L.
    Ueland, T.
    Aukrust, P.
    Solbu, D.
    Gullestad, L.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S32 - S32
  • [10] Three Year Follow Up of the Randomized SCHEDULE Trial With Everolimus Initiation and Early Withdrawal of Calcineurin Inhibitor Therapy in De Novo Heart Transplant Recipients - A Multicenter, Randomized Scandinavian Trial
    Andreassen, A. K.
    Andersson, B.
    Gustafsson, F.
    Eiskjaer, H.
    Radegran, G.
    Gude, E.
    Jansson, K.
    Solbu, D.
    Karason, K.
    Arora, S.
    Dellgren, G.
    Gullestad, I.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S129 - S130
12345